跳至主要内容
临床试验/DRKS00026746
DRKS00026746已完成不适用

Mortality and morbidity after transbronchial lung cryobiopsy - Cryo-mortality-study

niversitätsklinikum Krems0 个研究点目标入组 75 人开始时间: 2021年9月29日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
75

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
18 Years 至 99 Years(—)
性别
All

入选标准

  • Patients with radiologically proven DPLD requiring histological examination for further evaluation were chosen for inclusion in this study

排除标准

  • Exclusion criteria included any possible bleeding disorders (international normalized ratio (INR) >1.3, partial thromboplastin time (PTT) above normal range, thrombocytopenia < 100.000/µl), treatment with thienopyridines, oxygen saturation below 90% after delivery of oxygen at a maximum flow rate of 2 l per minute, pre-existing severe cardiac diseases (e.g. instable angina pectoris, myocardial infarction, decompensated cardiac insufficiency) or known echocardiographically measured pulmonary hypertension with a systolic pulmonary artery pressure greater than 50 mmHg

研究者

发起方
niversitätsklinikum Krems

相似试验

Mortality and morbidity after transbronchial lung... | 临床试验